logo
Ty Eschenbaum: how cancer and loss now helps others

Ty Eschenbaum: how cancer and loss now helps others

Yahoo17-05-2025

SIOUX FALLS, S.D. (KELO) —For many people, when they run into adversity or trying times, it's easy to give up and focus only on themselves. But one man that has taken his trials, and in turn, benefited others.
We've brought you the story of Ty Eschenbaum for years, starting when he had cancer in high school.
Early childhood center coming to Flandreau
'Diagnosed when I was 15 with leukemia and kind of a unique diagnosis in that I didn't have any classic symptoms. I, you know, ran region track meet like, three weeks before I ran one of my best quarter times,' Ty Eschenbaum said.
Like many people, that diagnosis changed his life.
'I went from, you know, lifting weights and playing sports and being 155 pounds down to at one point I was 105 pounds, couldn't walk, couldn't even stand, couldn't even hold my own weight,' Eschenbaum said.
It was during that bout with cancer, that Eschenbaum was granted a Make-a-Wish.
'Having my whole family involved was important to me. So I chose Disney World. So pretty original when it comes to Make-A-Wish, but it was awesome,' Eschenbaum said.
At that point in his life, he knew he wanted to do what he could for other children with cancer.
'There's a lot of families that we got to know and kids that I got to know that didn't make it. And I just felt strongly that I'm still here, and I'm supposed to do something with this,' Eschenbaum said.
In 2011, Eschenbaum officially started his foundation, when he wrote a check for $250. From there, it has only grown.
'We have three pillars of the foundation. So originally, we've always funded youth cancer survivors, in the form of scholarships in the state of South Dakota. I think we're the only entity that specifically does that in our state. And then, when I lost a younger brother, two and a half years ago, that's a pillar with our missionary ministry focus. And, five years ago, when I lost my girlfriend, that was the second pillar, the Make-A-Wish pillar,' Eschenbaum said.
Over the years, KELOLAND News has been there for some of Eschenbaum's donations to Make-A-Wish kids. His foundation has donated $315,000 to Make-A-Wish.
To help Eschenbaum and his foundation with its mission, a fishing and golf tournament is being held up near Lake Poinsett.
Jake Schoenbeck has attended The Summer Classic, and his employer Plains Commerce Bank is this year's presenting sponsor. He participates in the golf part of the tournament. He says that it's a little different from other golf tournaments.
'There's also like a DJ on one hole and he's like, playing music with there's a bar there that will drive around like jello shots and stuff like that. There's games and stuff,' Jake Schoenbeck said.
'It starts off with a lot of excitement on Friday morning because the golfers are running around and they're trying to get warmed up and then, you know, the entertainment of just watching the teams take off and get moving in and shaking and just the organization of the whole event is just fun to watch,' Lynn Jurrens said.
The fishing aspect of the tournament is something that also has a high appeal.
Lynn Jurrens has attended the Summer Classic since it started.
'The reason there's so many fishing teams that show up is because you can have, multiple people in the boat if you want to take your family, if you want to take your friends, if you want to take a kid fishing for the day, it all works out just really, really cool,' Jurrens said.
But what makes all the difference to the attendees, is what their money is going towards.
'I'm going to be out golfing almost every weekend anyway. So when you get to do it for an event like that, to kind of just makes it a little more special. You're more willing to, you know, throw money at things, whether it's some stupid game you're going to play and try to get another shot in the hole, or you're chipping into this little basket to try to get a closer drive,' Schoenbeck said.
'People are just excited. They want to be a part of it. They want to raise money, and they want to raise money because they feel that it's being used wisely,' Jurrens said.
And watching Eschenbaum at the helm of the charge is something that sticks out.
'Losing his fiance, losing his brother, him having cancer, all these things and still being such a powerful voice and being everywhere in the community. I feel like every time I'm out at a big event, Ty's there,' Schoenbeck said.
'That character, the resilience to overcome, those are attractive traits in people. And, they're special people to be around. And we, as the lucky people that get to be around him, can build off that. That's what's special about Ty,' Jurrens said.
The Summer Classic takes place on June 6th and 7th, but space is limited.
Click here for more information about The Summer Classic.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

ADA Issues New MASLD Guidelines
ADA Issues New MASLD Guidelines

Medscape

time22 minutes ago

  • Medscape

ADA Issues New MASLD Guidelines

A new consensus report from the American Diabetes Association (ADA) provides a practice-oriented framework for screening and managing metabolic dysfunction–associated steatotic liver disease (MASLD) in people with diabetes and prediabetes. Published online on May 28, 2025, in Diabetes Care, the report is a comprehensive update to the recommendations the ADA released in 2023. It is intended for clinicians treating patients with diabetes — primarily type 2 diabetes (T2D) — but also type 1 diabetes with obesity and prediabetes. Topics covered include the rationale for the recent change in terminology, epidemiology, fibrosis risk stratification, monitoring, treatment, and referral guidance, with interprofessional team management emphasized throughout. 'This will provide primary care doctors and anyone taking care of people with diabetes the tools to diagnose [MASLD] early and guide therapy…to prevent cirrhosis, and refer to the hepatologist as needed for additional therapy and monitoring,' lead author Kenneth Cusi, MD, professor of medicine at the Division of Endocrinology, Diabetes & Metabolism in the Department of Medicine at the University of Florida, Gainesville, Florida, told Medscape Medical News . The guidelines recommend that clinicians routinely screen people with T2D or prediabetes for MASLD. 'We explain that the liver should be incorporated into our management in the same way we do for chronic kidney disease, eye disease, and nerve disease as an end-organ damage that is particularly affected by diabetes,' Cusi said. In the United States, at least 70% of people with T2D have MASLD, about half of whom have the more progressive form termed metabolic dysfunction–associated steatohepatitis (MASH). About 1 in 5 with T2D have advanced liver fibrosis. The presence of MASH increases the risks for complications including cirrhosis, hepatocellular carcinoma, and overall mortality, according to the new consensus report. Liver disease has not been a focus of diabetes management until recently, Cusi noted. 'We didn't think about it. The epidemic of obesity, and with that, of diabetes, is driving this liver disease. The obesity epidemic has had a big worsening since the 1990s, so this damage in the past 20 or 30 years is just now becoming evident in the liver.' Terminology Change: Highlighting Insulin Resistance, Reducing Stigma The document reviews the current nomenclature for SLD, which was officially changed in 2023 to remove the words 'fatty' and 'alcoholic.' Now, MASLD is defined as the presence of SLD with at least one metabolic risk factor such as obesity, hypertension, prediabetes, high triglycerides, low high-density lipoprotein cholesterol, or T2D, with minimal or no alcohol consumption (< 20 g/d for women; < 30 g/d for men). The term 'MetALD' is used for those with MASLD who also have increased alcohol consumption (20-50 g/d for women; 30-60 g/day for men). Steatosis in the setting of alcohol consumption above those levels is termed 'alcohol-associated liver disease (ALD).' The term MASH is defined as steatohepatitis with at least one metabolic risk factor and minimal alcohol consumption. 'At-risk MASH' refers to steatohepatitis with clinically significant fibrosis (stage F2 or higher). Diagnosis: Staged Screening for Fibrosis The document recommends routine screening of people with T2D, prediabetes, and/or obesity with cardiovascular risk factors, with the goal of identifying those with high-risk MASH. Intervention is then aimed at preventing fibrosis progression and cirrhosis. A graphic diagnostic algorithm advises initial use of the noninvasive Fibrosis-4 (FIB-4) tool, which risk stratifies based on age, liver enzymes, and platelet count. 'The FIB-4 is composed of very simple things that are already in the electronic medical record of all patients. We also discuss the role of electronic medical records to improve implementation,' Cusi said. Those with a FIB-4 < 1.3 have a low risk for future cirrhosis and can be managed in primary or team care with optimized lifestyle and repeated FIB-4 every 1-2 years. If the FIB-4 is > 2.67, direct referral to a liver specialist is advised. If FIB-4 is between 1.3 and 2.67, a second risk-stratification test is recommended. Ideally, this would be a liver stiffness measurement (LSM), most commonly with transient elastography. If that is unavailable, an alternative is the noninvasive enhanced liver fibrosis (ELF) test. If the LSM is < 8.0 kPa or ELF is < 7.7, the fibrosis risk is low and routine management can continue with repeat testing in 1-2 years. But if higher, hepatology referral is recommended. Treatment: Lifestyle, Plus Old and New Drugs The report details lifestyle modification for MASLD, including nutrition plans; physical activity; behavioral health; and the role of diabetes self-management, education and support. The role of obesity treatment in people with MASLD, both metabolic surgery and pharmacotherapy, is also discussed at length. No current pharmacologic treatments have been approved for MASLD, but both semaglutide and tirzepatide have demonstrated benefit in treating MASH and are approved for treating T2D, obesity, and other related comorbidities. A thyroid hormone receptor beta agonist, resmetirom, was approved in early 2024 for the treatment of MASH with fibrosis stages F2 and F3, but is extremely expensive at about $50,000 a year, Cusi noted. An older, generic glucose-lowering drug, pioglitazone, has also shown benefit in reducing fibrosis and may be a lower-cost alternative. The document also includes a section on alcohol intake, which complicates the MASLD picture, Cusi noted. 'We think that this is going to help doctors to consider alcohol, which is often overlooked and under-reported. If patients have moderate fibrosis, they should completely quit alcohol.' Cusi has received research support (to his institution) from Boehringer Ingelheim, Echosens, Inventiva, Labcorp, and Perspectum, and has served as a consultant for Aligos Therapeutics, Arrowhead, AstraZeneca, 89bio, Bristol-Myers Squibb, Boehringer Ingelheim, Eli Lilly, GlaxoSmithKline, Novo Nordisk, ProSciento, Sagimet Biosciences, Siemens USA, Zealand Pharma, and Terns Pharmaceuticals.

Finding Strength Through Chronic Illness
Finding Strength Through Chronic Illness

Fox News

time42 minutes ago

  • Fox News

Finding Strength Through Chronic Illness

Roughly 133 million people in the U.S. struggle with chronic illnesses every day, and yet they're rarely talked about. Struggling with a chronic illness can oftentimes feel isolating when the pain endured is invisible, or when it feels impossible to explain what it's like to live in constant fear that severe pain could be on the horizon. For Tina Medlin, who's been living with Crohn's disease for roughly 30 years, she knew these feelings well. But instead of just accepting them as the norm, she set out to create a community where those with chronic illnesses feel supported, cared for, and heard. Tina discusses how this mission led her to pioneer the Warrior Braids Ministry, a Christ-centered nonprofit that offers resources, support and community to those who live with chronic illnesses. Follow Benjamin on X: @BenjaminHallFNC Learn more about your ad choices. Visit

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store